| Literature DB >> 31938707 |
Jae-Ryang Yoon1, Gi-Chul Ha1, Seol-Jung Kang2, Kwang-Jun Ko3.
Abstract
This study aimed to determine the effects of resistance exercise and interval training on the visceral fat to skeletal muscle area, physical fitness, cognitive functions, and mental health in old women. The study was conducted among 30 older women enrolled in the National Fitness Center in Seoul. They were randomly sampled into the resistance exercise and interval training group (RI group: n=10, aged 64.10±3.35), the resistance and aerobic exercise group (RA group: n=10, aged 65.20± 5.10), and the control group (n=10, aged 63.20±2.62). Twelve weeks of exercise involving 30-min resistance exercise followed by 30-min interval training or aerobic exercise, 3 times a week, were performed by each group. A computed topography was used to the measure visceral fat area and the thigh skeletal muscle area. For physical fitness, maximum oxygen uptake, knee isokinetics muscle functions, ankle range of motion, and functional fitness of the elderly (muscle strength, cardiorespiratory endurance, flexibility, balance, and agility) were measured. For blood test, the metabolic syndrome risk factors, growth hormone, testosterone, and insulin-like growth factor-1 (IGF-1) were measured. A self-administered questionnaire was used to measure cognitive functions and quality of sleep. The 12-week RA and RI groups were effective in changing the thigh skeletal muscle area, IGF-1, knee joint extension and flexion, ankle range of motion, functional fitness, and quality of sleep. In conclusion, resistance exercise, followed by interval training or aerobic exercise, was effective in improving the skeletal muscle function indexes, physical fitness, and quality of sleep for the elderly. However, no difference was found between the two types of exercise.Entities:
Keywords: Cognitive function; Elderly women; Physical fitness; Quality of sleep; Resistance exercise and interval training; Visceral fat/skeletal muscle area
Year: 2019 PMID: 31938707 PMCID: PMC6944885 DOI: 10.12965/jer.1938644.322
Source DB: PubMed Journal: J Exerc Rehabil ISSN: 2288-176X
Physical characteristics of subjects
| Group | Age (yr) | Height (cm) | Weight (kg) | BMI (kg/m2) | Body fat (%) |
|---|---|---|---|---|---|
| RI (n=10) | 64.10±3.35 | 159.11±5.08 | 58.66±6.90 | 23.11±1.69 | 31.87±3.73 |
| RA (n=10) | 65.20±5.10 | 154.26±4.18 | 53.13±3.85 | 22.34±1.67 | 30.49±2.73 |
| Control (n=10) | 63.20±2.62 | 159.01±4.39 | 56.56±7.81 | 22.32±2.41 | 30.43±4.23 |
| 0.513 | 0.038 | 0.170 | 0.593 | 0.608 |
Values are presented as mean±standard deviation.
RI, resistance and interval training; RA, resistance and aerobic exercise; BMI, body mass index.
Change in body composition and computed tomography scan measurement
| Variable | RI group | RA group | Control group | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
| Pre | Post | Pre | Post | Pre | Post | Group | Time | Interaction | |
| Body composition | |||||||||
| Weight (kg) | 58.66±6.90 | 58.70±7.65 | 53.13±3.85 | 53.79 ±3.78 | 56.56±7.81 | 57.44±7.95 | 0.209 | 0.038 | 0.353 |
| BMI (kg/m2) | 23.11±1.69 | 23.07±2.08 | 22.34±1.67 | 22.64±1.53 | 22.32±2.41 | 22.60±2.38 | 0.725 | 0.105 | 0.362 |
| Body fat (%) | 31.87±3.73 | 31.88±3.69 | 30.49±2.73 | 30.82±3.04 | 30.43±4.23 | 30.96±4.21 | 0.695 | 0.128 | 0.519 |
|
| |||||||||
| CT scan measurement | |||||||||
| TFA (cm2) | 434.16±64.93 | 434.76±89.58 | 422.60±50.14 | 420.94±47.96 | 414.96±67.83 | 418.77±66.77 | 0.811 | 0.907 | 0.960 |
| Subcutaneous (cm2) | 246.99±57.09 | 245.22±62.61 | 217.29±27.64 | 210.34±28.77 | 228.03±49.02 | 221.57±48.31 | 0.274 | 0.403 | 0.926 |
| Visceral (cm2) | 187.17±22.48 | 189.54±33.75 | 205.31±39.01 | 206.81±35.59 | 186.93±34.78 | 193.14±31.84 | 0.400 | 0.373 | 0.859 |
| VSR | 0.43±0.58 | 0.44±0.41 | 0.47±0.60 | 0.48±0.51 | 0.45±0.71 | 0.46±0.52 | 0.197 | 0.115 | 0.780 |
| Skeletal muscle area (cm2) | 106.47±16.65 | 117.38±18.36 | 106.24±14.54 | 113.43±15.21 | 106.30±14.42 | 107.29±14.83 | 0.751 | 0.000 | 0.002 |
| VMR | 1.79±0.27 | 1.64±0.37 | 1.94±0.27 | 1.85±0.38 | 1.76±0.24 | 1.81±0.26 | 0.402 | 0.123 | 0.114 |
Values are presented as mean±standard deviation.
RI, resistance and interval; RA, resistance and aerobic; BMI, body mass index; TFA, total fat area; VSR, visceral to subcutaneous ratio; VMR, visceral fat to skeletal muscle area ratio.
Change in metabolic syndrome risk factors and hormone
| Variable | RI group | RA group | Control group | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
| Pre | Post | Pre | Post | Pre | Post | Group | Time | Interaction | |
| SBP (mmHg) | 122.90±16.60 | 119.70±13.64 | 123.60±14.13 | 118.10±14.73 | 125.90±15.24 | 126.90±16.22 | 0.641 | 0.113 | 0.247 |
|
| |||||||||
| DBP (mmHg) | 75.10±12.97 | 74.20±12.79 | 74.70±10.95 | 72.00±9.73 | 76.70±9.68 | 77.80±10.67 | 0.697 | 0.596 | 0.613 |
|
| |||||||||
| TG (mg/dL) | 93.60±29.02 | 91.30±27.13 | 102.30±65.02 | 102.50±56.20 | 72.00±27.93 | 68.90±32.89 | 0.195 | 0.773 | 0.972 |
|
| |||||||||
| HDL-C (mg/dL) | 61.10±12.37 | 54.40±11.72 | 60.80±10.40 | 61.60±14.84 | 65.60±11.43 | 61.00±10.72 | 0.515 | 0.084 | 0.286 |
|
| |||||||||
| LDL-C (mg/dL) | 132.30±44.91 | 116.90±25.63 | 104.10±24.11 | 104.50±28.95 | 111.90±26.73 | 115.50±17.28 | 0.196 | 0.520 | 0.376 |
|
| |||||||||
| FBG (mg/dL) | 93.70±6.68 | 91.90±8.60 | 94.40±5.62 | 92.40±16.59 | 97.70±13.94 | 97.50±7.20 | 0.265 | 0.649 | 0.962 |
|
| |||||||||
| GH (ng/mL) | 1.54±1.38 | 1.44±1.94 | 1.34±0.57 | 1.15±0.93 | 1.46±1.15 | 1.16±0.78 | 0.869 | 0.334 | 0.917 |
|
| |||||||||
| IGF-1 (ng/mL) | 132.40±28.43 | 157.28±40.81 | 127.71±25.54 | 136.60±20.19 | 130.27±20.79 | 135.00±30.50 | 0.454 | 0.014 | 0.226 |
|
| |||||||||
| Testosterone (ng/dL) | 0.08±0.07 | 0.14±0.16 | 0.17±0.28 | 0.17±0.06 | 0.10±0.09 | 0.10±0.07 | 0.345 | 0.497 | 0.762 |
Values are presented as mean±standard deviation.
RI, resistance and interval; RA, resistance and aerobic; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; FBG, fasting blood glucose; GH, growth hormone; IGF-1, insulin-like growth factor-1.
Change in cardiorespiratory fitness, knee isokinetic function, and range of motion in foot joint
| Variable | RI group | RA group | Control group | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
| Pre | Post | Pre | Post | Pre | Post | group | time | Interaction | |
| VO2max (mL/kg/min) | 26.10±8.59 | 27.09±7.02 | 27.95±4.91 | 27.43±6.90 | 27.09±6.41 | 27.38±5.53 | 0.917 | 0.824 | 0.862 |
|
| |||||||||
| Rt Knee EX TQ/BW (Nm) | 154.59±46.98 | 182.85±48.29 | 156.78±33.71 | 181.93±32.80 | 166.27±47.57 | 163.64±47.45 | 0.969 | 0.000 | 0.000 |
|
| |||||||||
| Lt Knee EX TQ/BW (Nm) | 150.74±49.38 | 180.40±45.99 | 161.51±30.40 | 179.20±35.16 | 162.20±44.55 | 162.70±41.91 | 0.911 | 0.000 | 0.000 |
|
| |||||||||
| Rt Knee FX TQ/BW (Nm) | 69.15±21.25 | 84.31±21.19 | 69.24±15.65 | 79.39±12.55 | 67.91±11.86 | 64.20±18.68 | 0.309 | 0.006 | 0.010 |
|
| |||||||||
| Lt Knee FX TQ/BW (Nm) | 68.31±21.38 | 83.31±21.38 | 69.32±14.32 | 78.51±15.13 | 70.35±16.23 | 70.76±26.02 | 0.802 | 0.000 | 0.000 |
|
| |||||||||
| Lt. ankle PF (°) | 51.26±3.87 | 53.30±3.80 | 51.34±4.16 | 52.20±4.13 | 51.19±5.46 | 51.10±4.95 | 0.848 | 0.000 | 0.000 |
|
| |||||||||
| Lt. ankle DF (°) | 19.40±1.50 | 20.66±1.50 | 19.96±1.62 | 20.33±1.63 | 19.91±2.12 | 19.85±1.98 | 0.862 | 0.000 | 0.000 |
|
| |||||||||
| Rt. ankle PF (°) | 51.26±3.86 | 53.14±3.87 | 51.34±5.32 | 52.13±5.25 | 51.19±5.96 | 51.48±5.29 | 0.927 | 0.000 | 0.012 |
|
| |||||||||
| Rt. ankle DF (°) | 19.94±1.50 | 20.70±1.70 | 19.96±2.07 | 20.20±2.04 | 19.91±2.32 | 19.90±2.33 | 0.899 | 0.000 | 0.002 |
Values are presented as mean±standard deviation.
RI, resistance and interval; RA, resistance and aerobic; Rt Knee EX TQ/BW, right knee-extensor peak torque/body weight; Lt knee EX TQ/BW, left knee-extensor peak torque/body weight; Rt Knee FX TQ/BW, right knee-flexion peak torque/body weight; Lt Knee FX TQ/BW, Left knee-flexion peak torque/body weight; Lt, left; Rt, right; PF, plantar flexion; DF, dorsal flexion.
Change in functional fitness
| Variable | RI group | RA group | Control group | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
| Pre | Post | Pre | Post | Pre | Post | group | time | Interaction | |
| Grip strength (kg) | 24.39±4.63 | 24.76±4.36 | 24.66±4.19 | 24.84±4.79 | 24.26±3.09 | 24.69±2.39 | 0.987 | 0.324 | 0.948 |
|
| |||||||||
| Arm curl (reps/30 sec) | 21.90±3.60 | 27.80±3.58 | 22.10±5.34 | 26.10±3.81 | 22.40±3.60 | 23.10±1.45 | 0.315 | 0.000 | 0.036 |
|
| |||||||||
| Chair stand (reps/30 sec) | 22.30±3.80 | 27.10±3.38 | 21.90±3.75 | 25.30±3.53 | 22.30±5.68 | 23.80±4.47 | 0.643 | 0.000 | 0.029 |
|
| |||||||||
| 2-Min step (reps) | 123.40±11.41 | 134.90±10.19 | 122.8±17.57 | 133.00±7.86 | 123.00±11.56 | 126.30±13.50 | 0.650 | 0.000 | 0.219 |
|
| |||||||||
| Chair sit & reach (cm) | 20.67±8.21 | 26.48±7.45 | 21.38±5.65 | 25.50±5.42 | 21.33±7.63 | 21.26±6.40 | 0.688 | 0.000 | 0.010 |
|
| |||||||||
| Back scratch (cm) | 6.10±9.01 | 5.05±9.00 | 5.70±7.03 | 4.35±6.52 | 5.30±8.00 | 5.65±8.65 | 0.987 | 0.023 | 0.048 |
|
| |||||||||
| Functional reach (cm) | 22.50±3.09 | 24.54±1.99 | 21.50±4.22 | 22.29±3.80 | 23.93±4.17 | 24.49±4.02 | 0.225 | 0.146 | 0.693 |
|
| |||||||||
| One-leg stance (sec) | 11.23±10.59 | 11.49±6.55 | 11.04±11.31 | 11.30±2.70 | 10.61±3.16 | 10.78±2.51 | 0.966 | 0.880 | 1.000 |
|
| |||||||||
| 2.45-m up-and-go (sec) | 3.99±0.73 | 3.09±0.60 | 3.97±0.56 | 3.47±0.35 | 3.83±0.28 | 3.91±0.37 | 0.270 | 0.000 | 0.000 |
Values are presented as mean±standard deviation.
RI, resistance and interval; RA, resistance and aerobic.
Change in cognitive function
| Variable | RI group | RA group | Control group | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
| Pre | Post | Pre | Post | Pre | Post | Group | Time | Interaction | |
| Memory ability (score) | 2.40±1.96 | 2.80±1.69 | 2.50±1.27 | 2.60±1.17 | 2.90±1.10 | 2.70±1.34 | 0.907 | 0.634 | 0.507 |
|
| |||||||||
| Language ability (score) | 2.20±1.03 | 1.60±1.08 | 2.00±1.49 | 1.50±0.97 | 1.50±1.72 | 1.80±0.92 | 0.832 | 0.382 | 0.418 |
|
| |||||||||
| Daily living ability (score) | 0.30±0.48 | 0.30±0.48 | 0.00±0.00 | 0.10±0.32 | 0.20±0.42 | 0.30±0.68 | 0.220 | 0.550 | 0.913 |
|
| |||||||||
| Total (score) | 4.90±2.51 | 4.70±2.35 | 4.50±2.59 | 4.20±1.62 | 4.60±2.46 | 4.80±2.04 | 0.867 | 0.815 | 0.879 |
Values are presented as mean±standard deviation.
RI, resistance and interval; RA, resistance and aerobic.
Change in sleep quality
| Variable | RI group | RA group | Control group | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
| Pre | Post | Pre | Post | Pre | Post | Group | Time | Interaction | |
| Subjective sleep quality (score) | 1.80±0.42 | 1.80±0.42 | 2.00±0.47 | 1.90±0.57 | 2.30±0.95 | 2.30±0.95 | 0.229 | 0.582 | 0.736 |
|
| |||||||||
| Sleep latency (score) | 2.10±0.57 | 1.80±0.63 | 1.70±0.95 | 1.30±0.67 | 1.70±0.82 | 1.70±0.82 | 0.371 | 0.031 | 0.270 |
|
| |||||||||
| Sleep duration (score) | 1.00±0.94 | 0.80±0.79 | 0.70±1.16 | 0.70±1.16 | 0.90±0.74 | 0.90±0.74 | 0.858 | 0.145 | 0.125 |
|
| |||||||||
| Habitual sleep efficiency (score) | 0.70±0.67 | 0.50±0.71 | 0.40±0.97 | 0.40±0.97 | 0.40±0.97 | 0.40±0.97 | 0.841 | 0.145 | 0.125 |
|
| |||||||||
| Sleep disturbances (score) | 2.10±0.74 | 2.00±0.82 | 2.10±0.32 | 1.90±0.57 | 2.20±0.63 | 2.20±0.63 | 0.707 | 0.388 | 0.775 |
|
| |||||||||
| Use of sleeping medication (score) | 1.30±0.67 | 1.00±0.00 | 1.10±0.32 | 1.10±0.32 | 1.00±0.00 | 1.00±0.00 | 0.452 | 0.171 | 0.158 |
|
| |||||||||
| Day time dysfunction (score) | 1.60±0.52 | 1.30±0.48 | 1.30±0.48 | 1.30±0.48 | 1.40±0.84 | 1.40±0.84 | 0.858 | 0.060 | 0.034 |
|
| |||||||||
| Total (score) | 10.60±1.17 | 9.20±2.04 | 9.30±2.31 | 8.60±2.55 | 9.90±3.45 | 9.90±3.57 | 0.645 | 0.001 | 0.014 |
Values are presented as mean±standard deviation.
RI, resistance and interval; RA, resistance and aerobic.